SCHEMBL6742580

SCHEMBL6742580

FC(F)(F)c1cc(O[CH]Cc2cccnc2)cc(C(F)(F)F)c1

nearest known ligand 0.43

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 2/20 0.43
POLB P06746 1/20 0.43
CACNA1H O95180 1/20 0.42
VNN1 O95497 3/20 0.41
CYP11B1 P15538 1/20 0.39
CYP11B2 P19099 1/20 0.39
SORT1 Q99523 1/20 0.39
GRIN1 Q05586 1/20 0.38
GRIN2B Q13224 1/20 0.38
SIGMAR1 Q99720 1/20 0.38
PTPN1 P18031 1/20 0.38
FDPS P14324 1/20 0.38
KIF11 P52732 1/20 0.38
LMNA P02545 1/20 0.37
HSD17B10 Q99714 1/20 0.37
TACR1 P25103 1/20 0.37
MEN1 O00255 1/20 0.37
KMT2A Q03164 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7381239 0.80 CACNA1H (0.45) KDM4EPOLBCACNA1HVNN1SORT1
SCHEMBL7382021 0.80 CACNA1H (0.45) KDM4EPOLBCACNA1HVNN1SORT1
SCHEMBL7380196 0.78 MAPT (0.43) KDM4E
SCHEMBL7379186 0.77 LTA4H (0.45) KDM4ECYP11B1CYP11B2LMNA
SCHEMBL7375133 0.75 CYP19A1 (0.42) VNN1CYP11B1CYP11B2HSD17B10
SCHEMBL18002137 0.70 PTPN1 (0.45) POLBPTPN1LMNA
SCHEMBL6629615 0.69 CHRNB2 (0.48)
SCHEMBL18002080 0.68 CYP11B1 (0.48) CYP11B1CYP11B2GRIN1GRIN2BPTPN1
SCHEMBL30062626 0.67 CACNA1H (0.53) KDM4EPOLBCACNA1HVNN1CYP11B1
SCHEMBL1515345 0.66

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6689771-B2 TREATMENT OF RHEUMATOID ARTHRITIS, OSTEOARTHRITIS, PERIODONTITIS, GINGIVITIS, CORNEAL ULCERATION, SOLID TUMOR GROWTH BRISTOL-MYERS SQUIBB PHARMA COMPANY 2004-02-10 US disclosed
US-6376665-B1 ANTIARTHRITIC AGENTS, ANTIINFLAMMATORY AGENTS BRISTOL-MYERS SQUIBB PHARMA COMPANY 2002-04-23 US disclosed
EP-1165500-A1 AMIDE DERIVATIVES AS INHIBITORS OF MATRIX METALLOPROTEINASES,TNF-ALPHA,AND AGGRECANASE Du Pont Pharmaceuticals Company (US) 2002-01-02 EP disclosed
WO-2000059874-A1 NOVEL AMIDE DERIVATIVES AS INHIBITORS OF MATRIX METALLOPROTEINASES, TNF-α, AND AGGRECANASE DU PONT PHARMACEUTICALS COMPANY (US) 2000-10-12 WO disclosed